Scleroderma Clinical Trials Consortium Inc.
Fiscal year ending 2024. Filed on September 11, 2025.
Bu Sch Medicine 718 Albany St E-5
717 Delaware St SE
Boston, Massachusetts 02118
Scleroderma Clinical Trials Consortium Inc. (EIN: 04-3543489) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Scleroderma Clinical Trials Consortium Inc., a 501(c)(3) charitable organization, reported compensation for 4 employees. Among the employees shown here, the average compensation is $0.
Revenue, expenses, and employee compensation
Revenue
$326,433
Expenses
$298,602
Employee compensation
$0
Reported Compensated Employees
Mission Statement
TO FOSTER SCIENTIFIC RESEARCH AND TO ADVANCE MEDICAL RESEARCH IN THE FORM OF TREATMENT TRIALS IN SCLERODERMA ON A WORLDWIDE BASIS.
Revisions to this organization profile
September 11, 2025:
2024 Scleroderma Clinical Trials Consortium Inc. 990 filed
November 15, 2024:
2023 Scleroderma Clinical Trials Consortium Inc. 990 filed
March 21, 2023:
2022 Scleroderma Clinical Trials Consortium Inc. 990 filed
Get an email when new compensation information is released for Scleroderma Clinical Trials Consortium Inc.
Be the first to know when new IRS Form 990 data is published for this organization.